Bronchiolitis |
Chronic Bronchitis |
Clinical Trial: Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants
This study is not yet open for patient recruitment.
Verified by Bnai Zion Medical Center December 2005
|
Purpose
| Condition | Intervention | Phase |
|---|---|---|
| Bronchiolitis | Drug: Inhaled Furosemide vs Placebo (Normal Saline) | Phase I |
MedlinePlus related topics: Bronchitis; Respiratory Syncytial Virus Infections
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Secondary Outcomes: 1. The duration of hospitalization; 2. Time weaned off oxygen; 3. Time to full enteral feeding
Study start: December 2005; Expected completion: April 2006
Last follow-up: April 2006; Data entry closure: April 2006
Eligibility
Inclusion Criteria:
• Age: 0-12 months. • Infants who are otherwise healthy • Infants with chronic lung disease of prematurity (BPD) will be included, but will be analyzed separately.
• Parents signed a written informed consent.
Exclusion Criteria:
- • Other previous or co-morbidity, specifically: respiratory (other than BPD, like Asthma or Cystic Fibrosis), cardiac or renal disease or anomaly.
Location and Contact Information
Israel
Bnai Zion Medical Center and Naharia Galilli Medical Center, Haifa, 31048, Israel
Amir Kugelman, Principal Investigator, Bnai Zion Medical Center
More Information
Last Updated: December 8, 2005
Record first received: December 5, 2005
ClinicalTrials.gov Identifier: NCT00261937
Health Authority: Israel: Ministry of Health
ClinicalTrials.gov processed this record on 2006-01-10

Not Signed In -


